Financials

  • Market Capitalization 546.83 M
  • Employee 23
  • Founded 2014
  • CEO N/A
  • Website www.ovidrx.com
  • Headquarter Delaware, United States
  • FIGI BBG009F0TD76
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-12.81
Rapporto prezzo/fatturato
168.21

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2863
PROK
ProKidney Corp. - Class A Ordinary Shares
1.83 USD+0.55%+15.09%+18.83%-12.02%553.25 M USD
2864
ZURA
Zura Bio Limited - Class A Ordinary shares
5.72 USD-2.22%-1.55%+4.76%+184.58%548.14 M USD
2870
ARTV
Artiva Biotherapeutics, Inc. - Common Stock
11.09 USD-7.12%+2.40%+10.90%+166.59%542.19 M USD
2885
CABA
Cabaletta Bio, Inc. - Common Stock
3.12 USD-7.69%+0.97%+16.85%+112.24%528.98 M USD

Notizie